Nature Biotechnology · Related

Nature Biotechnology — Nature Portfolio biotech journal, launched 1983. Monthly, Impact Factor ~68. Gene editing, synthetic biology, biologics, vaccines..

Nature Biotechnology is classified as a tier-2 journal-med within the knowledge graph. It intersects with multiple scopes and has dedicated desk feeds, making it a go-to reference for practitioners.

Cities most closely associated with this topic include Aarhus, Abeokuta, Aberdeen. Relevance is computed via the unified entity graph using continent, country, and industry-hub tagging.

Nature Biotechnology connects out to: Nature Genetics, Nature Medicine, Cell. Each of those topics carries its own cross-nav rail, OPML bundle, FAQ, and printable summary.

Yes — the 📡 OPML link in the flows strip downloads a curated bundle of RSS feeds covering Nature Biotechnology, importable into Feedly, Inoreader, NetNewsWire, or any OPML-compatible reader.

The Daily Pulse (📊) is a real-time rolling feed of news, policy updates, and market events tagged to Nature Biotechnology. Access it at /desk/pulse.php?entity=topic::journal-nat-biotech.

Topic Briefs (📄) are daily-synthesised editorial digests specifically for Nature Biotechnology. They aggregate pulse items into structured summaries with context, citations, and implications.

Trade, tax, duty, and Incoterms tools apply to Nature Biotechnology when a shipment or transaction context is invoked. Access the full tool suite at /tools/.

Yes — the Print/PDF button produces a single-page summary of Nature Biotechnology covering definition, scopes, related cities, related topics, cross-references, and FAQ.

Nature Biotechnology automatically links into relevant AJG scopes — every scope page surfaces topics like Nature Biotechnology as part of its coverage index.